A novel decoy strategy for polymyxin resistance in Acinetobacter baumannii
Abstract
Modification of the outer membrane charge by a polymyxin B (PMB)-induced PmrAB two-component system appears to be a dominant phenomenon in PMB-resistant Acinetobacter baumannii. PMB-resistant variants and many clinical isolates also appeared to produce outer membrane vesicles (OMVs). Genomic, transcriptomic, and proteomic analyses revealed that upregulation of the pmr operon and decreased membrane-linkage proteins (OmpA, OmpW and BamE) are linked to overproduction of OMVs, which also promoted enhanced biofilm formation. The addition of OMVs from PMB-resistant variants into the cultures of PMB-susceptible A. baumannii and the clinical isolates protected these susceptible bacteria from PMB. Taxonomic profiling of in vitro human gut microbiomes under anaerobic conditions demonstrated that OMVs completely protected the microbial community against PMB treatment. A Galleria mellonella-infection model with PMB treatment showed that OMVs increased the mortality rate of larvae by protecting A. baumannii from PMB. Taken together, OMVs released from A. baumannii functioned as decoys against PMB.
Data availability
1. Sequence reads for the experimentally evolved isolates are accessible from the NCBI sequence archives under accession numbers PRJNA530195 (Lab-WT), PRJNA530197 (PMRLow), and PRJNA530202 (PMRHigh).2. The RNA-seq data have been deposited in NCBI under Gene Expression Omnibus (GEO) accession number GSE163581.3. The bacterial community data have been deposited in NCBI under Sequence Read Archive (SRA) accession number SRX9819399 PRJNA689940, SRX9819397 PRJNA689944 and SRX9819398 PRJNA689944.
-
Acinetobacter baumannii strain:Lab-WT Genome sequencingNCBI Bioproject ID PRJNA530195.
-
Acinetobacter baumannii strain:PMR-Low Genome sequencingNCBI Bioproject ID PRJNA530197.
-
Acinetobacter baumannii strain: PMR-High Genome sequencingNCBI Bioproject ID PRJNA530202.
-
Transcriptome of Acinetobacter baumannii with or without polymyxin BNCBI Gene Expression Omnibus ID GSE163581.
-
fecal microbiota controlNCBI Bioproject ID SRX9819399 PRJNA689940.
-
PMBNCBI Bioproject ID SRX9819397 PRJNA689944.
-
OMV->PMB.NCBI Bioproject ID SRX9819398 PRJNA689944.
Article and author information
Author details
Funding
National Research Foundation of Korea (NRF-2020M3A9H5104237)
- Woojun Park
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2021, Park et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,288
- views
-
- 574
- downloads
-
- 33
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Microbiology and Infectious Disease
Protein NƐ-lysine acetylation (Kac) modifications play crucial roles in diverse physiological and pathological functions in cells. In prokaryotic cells, there are only two types of lysine deacetylases (KDACs) that are Zn2+- or NAD+-dependent. In this study, we reported a protein, AhCobQ, in Aeromonas hydrophila ATCC 7966 that presents NAD+- and Zn2+-independent KDAC activity. Furthermore, its KDAC activity is located in an unidentified domain (from 195 to 245 aa). Interestingly, AhCobQ has no homology with current known KDACs, and no homologous protein was found in eukaryotic cells. A protein substrate analysis showed that AhCobQ has specific protein substrates in common with other known KDACs, indicating that these KDACs can dynamically co-regulate the states of Kac proteins. Microbiological methods employed in this study affirmed AhCobQ’s positive regulation of isocitrate dehydrogenase (ICD) enzymatic activity at the K388 site, implicating AhCobQ in the modulation of bacterial enzymatic activities. In summary, our findings present compelling evidence that AhCobQ represents a distinctive type of KDAC with significant roles in bacterial biological functions.
-
- Microbiology and Infectious Disease
Influenza A virus transcribes viral mRNAs from the eight segmented viral genome when it infects. The kinetics of viral transcription, nuclear export of viral transcripts, and their potential variation between the eight segments are poorly characterised. Here, we introduce a statistical framework for estimating the nuclear export rate of each segment from a snapshot of in situ mRNA localisation. This exploits the cell-to-cell variation at a single time point observed by an imaging-based in situ transcriptome assay. Using our model, we revealed the variation in the mRNA nuclear export rate of the eight viral segments. Notably, the two influenza viral antigens hemagglutinin and neuraminidase were the slowest segments in the nuclear export, suggesting the possibility that influenza A virus uses the nuclear retention of viral transcripts to delay the expression of antigenic molecules. Our framework presented in this study can be widely used for investigating the nuclear retention of nascent transcripts produced in a transcription burst.